financetom
Business
financetom
/
Business
/
Top Premarket Gainers
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Top Premarket Gainers
Jul 1, 2024 5:20 AM

07:47 AM EDT, 07/01/2024 (MT Newswires) -- Chewy (CHWY) shares were up over 17% after stock influencer Keith Gill disclosed a 6.6% stake in the company.

Datasea ( DTSS ) stock was 9% higher following a 2.5% increase in the previous session.

Cassava Sciences ( SAVA ) shares were up 2%, shaving Friday's losses.

Price: 31.96, Change: +4.72, Percent Change: +17.33

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BlackRock bets on consumer push as it chases European savers
BlackRock bets on consumer push as it chases European savers
Mar 19, 2025
LONDON (Reuters) - BlackRock ( BLK ) is betting on an expanded range of retail-focused products, including more exchange-traded funds, to attract a new generation of Europeans into investing, an executive said, as it tries to outcompete local rivals slowly gaining ground. The U.S. fund manager, through its iShares unit, has a 43% market share in European ETFs, three times...
Sanofi to acquire Dren Bio's immunology unit
Sanofi to acquire Dren Bio's immunology unit
Mar 19, 2025
(Reuters) - Sanofi on Thursday announced an agreement with biopharmaceutical company Dren Bio for the acquisition of its autoimmune disease treatment DR-0201. The French healthcare group will acquire the Dren Bio affiliate Dren-0201 for an upfront payment of $600 million and potential future payments totalling $1.3 billion, it said in a statement. The transaction is expected to close in the...
Sodexo cuts 2025 guidance on slower growth in North America
Sodexo cuts 2025 guidance on slower growth in North America
Mar 19, 2025
(Reuters) - French food caterer Sodexo lowered its 2025 guidance on Thursday, citing slower than expected organic growth in North America. While our industry fundamentals remain strong, in North America the continued soft trend in volumes in Education and slower than expected net new ramp-up in Healthcare have impacted our ability to meet initial expectations, CEO and Chairwoman Sophie Bellon...
Eli Lilly launches weight-loss drug Mounjaro in India after drug regulator approval
Eli Lilly launches weight-loss drug Mounjaro in India after drug regulator approval
Mar 19, 2025
March 20 (Reuters) - Eli Lilly ( LLY ) has launched its blockbuster diabetes and weight-loss drug Mounjaro in India following approval from country's drug regulator, it said on Thursday. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved